RecruitingNot Applicable

A Prospective Study for the Early Diagnosis of Lung Cancer in Korean Females

South Korea200 participantsStarted 2024-06-01

Plain-language summary

This is a single-arm prospective pilot study in a single institution. The target accrual is 200 participants of Korean, female sex, never smoker status, and family history of lung cancer. The study will aim to enroll 200 participants in two years.

Who can participate

Age range

45 Years – 74 Years

Sex

FEMALE

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion criteria

. Age 45-74 years old
. Korean female
. Never smoker defined as a lifetime exposure of less than 100 cigarettes
. Family history of lung cancer at first degree relatives (parents, siblings, or children)

Exclusion criteria

. Prior history of lung cancer.
. Diagnosis of any cancer within the past five years
. Participation in a cancer prevention trial.
. Present symptoms suggestive of current lung cancer, including: unexplained weight loss of over 5 kilograms within the last 12 months or unexplained hemoptysis.
. Medical or psychiatric condition precluding informed medical consent.
. History of LDCT screening, chest CT, PET or PET/CT scan within 10 years

Questions worth asking your doctor

Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.

1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?

Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.

Questions for the trial coordinator

The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.

1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?

A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.

What they're measuring

Lung cancer detection rate

Timeframe: up to 2years

Trial details

NCT IDNCT06181929

SponsorSang-Won Um

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2026-05-31

Contact for this trial

Um Sang-Won, PhD

82-2-3410-1645 sangwonum72@gmail.com

View on ClinicalTrials.gov More Health Risk Behaviors trials